Skip to content

Clinical trials

Phase 1/2 Macular Edema trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Edema Phase: Phase 1/2 Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20092
20101
20114
20122
20143
20152
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated7
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)5
Icahn School of Medicine at Mount Sinai2
Johns Hopkins University2
Allergan1
AsclepiX Therapeutics, Inc.1
David M. Brown, M.D.1
Eyegate Pharmaceuticals, Inc.1
Hanscom, Thomas, M.D.1
Justis Ehlers1
Massachusetts Eye and Ear Infirmary1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Edema19
Retinal Vein Occlusion4
Uveitis4
Diabetes Mellitus3
Diabetic Retinopathy2
Cone-Rod Dystrophies1
Eye Diseases1
Macular Degeneration1
Retinal Degeneration1
Retinal Diseases1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.